{
  "meta": {
    "title": "00023_Mid_Day_Module_Medicine-6",
    "url": "https://brainandscalpel.vercel.app/00023-mid-day-module-medicine-6-05c60522.html",
    "scrapedAt": "2025-11-29T18:11:55.789Z"
  },
  "questions": [
    {
      "id": 53731,
      "choices": [
        {
          "id": 214397,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serial clinical and echocardiographic evaluations</span></span></p>"
        },
        {
          "id": 214398,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgical mitral valve repair</span></span></p>"
        },
        {
          "id": 214399,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Surgical mitral valve replacement</span></span></p>"
        },
        {
          "id": 214400,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transcatheter mitral valve repair</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old woman came for a routine health check-up. She has no symptoms, and on examination, she has a grade 4/6 holosystolic murmur at the apex. 2D Echo demonstrates severe Mitral regurgitation with LVEF of 50%. The left ventricle is moderately dilated with an LV end-systolic dimension (LVESD) of 42 mm. Which of the following is the most appropriate next step in management?</span></span></span></p>",
      "unique_key": "Q1775819",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391903,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Surgical mitral valve repair</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient has severe mitral regurgitation (MR) with left ventricular (LV) dilatation. Although she is currently asymptomatic, the presence of severe MR with EF &le; 60% and LV enlargement (ESD &ge; 40mm) indicates a high risk of future heart failure and adverse outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Repair is preferred over replacement as it preserves the native valve and avoids the need for long-term anticoagulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Serial clinical and echocardiographic evaluations:</span></strong><span style=\"font-size:12.0pt\"> While monitoring is important, it is not the most appropriate next step in this case of severe MR with LV dilatation. Delaying surgery can lead to irreversible LV damage and worsening of symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Surgical mitral valve replacement:</span></strong><span style=\"font-size:12.0pt\"> Replacement is considered if repair is not feasible or if the mitral valve is severely damaged. However, repair is the preferred option whenever possible.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Transcatheter mitral valve repair:</span></strong><span style=\"font-size:12.0pt\"> This is a less invasive option but is currently recommended for patients who are high-risk surgical candidates. This patient is asymptomatic and otherwise healthy, making her a good candidate for surgical repair.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Indications for surgical mitral valve repair in asymptomatic patients include severe primary MR and LV dilatation (ESD &ge; 40mm and/or EF &le; 60%). </span></span></p>",
      "correct_choice_id": 214398,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53734,
      "choices": [
        {
          "id": 214409,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic stenosis</span></span></p>"
        },
        {
          "id": 214410,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac tamponade</span></span></p>"
        },
        {
          "id": 214411,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral regurgitation</span></span></p>"
        },
        {
          "id": 214412,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tricuspid regurgitation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 66-year-old man presents with recurrent chest pain and dyspnea. He has a history of hypertension and hyperlipidemia. Physical exam reveals elevated JVP, crackles, and a soft early systolic murmur with an S3 gallop. ECG is shown. Chest X-ray shows pulmonary congestion. What is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-180925.jpg\" style=\"height:259px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q5143210",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391904,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Mitral regurgitation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation is consistent with acute mitral regurgitation (MR) secondary to an inferolateral myocardial infarction (MI). The ECG findings is suggestive of inferior MI with possible posterior MI (see lead V2) and its likely that posteromedial papillary muscle is ruptured in this case (which is supplied by the RCA), leading to Acute MR. The clinical findings of elevated JVP, pulmonary congestion, and an S3 gallop support the diagnosis of acute heart failure, which is a consequence of the severe MR. The soft early systolic murmur and diastolic rumble are also characteristic of MR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aortic stenosis:</span></strong><span style=\"font-size:12.0pt\"> While this can cause heart failure, it would present with a harsh systolic murmur radiating to the carotids, not a soft early systolic murmur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Cardiac tamponade:</span></strong><span style=\"font-size:12.0pt\"> This can cause elevated JVP and distant heart sounds, but it would not typically present with a new murmur or ECG changes of MI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tricuspid regurgitation:</span></strong><span style=\"font-size:12.0pt\"> This would cause a holosystolic murmur that increases with inspiration, not the early systolic murmur described in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute MR usually occurs in association with inferior MI and it is due to rupture of posteromedial papillary muscle. </span></span></p>",
      "correct_choice_id": 214411,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53740,
      "choices": [
        {
          "id": 214433,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esmolol continuous IV infusion titrated to a heart rate of 60&ndash;70 beats/min </span></span></p>"
        },
        {
          "id": 214434,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intra-aortic balloon pump</span></span></p>"
        },
        {
          "id": 214435,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV nitroprusside </span></span></p>"
        },
        {
          "id": 214436,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV norepinephrine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 21-year-old woman with a history of connective tissue disease presents with acute shortness of breath and pulmonary edema. Examination reveals severe aortic regurgitation due to a right coronary cusp avulsion. She is in cardiogenic shock. What intervention is most likely to maintain end-organ perfusion until surgery?</span></span></span></p>",
      "unique_key": "Q7395275",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391905,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) IV nitroprusside</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is experiencing acute, severe aortic regurgitation leading to cardiogenic shock. The goal is to reduce regurgitant blood volume and improve forward flow. Nitroprusside, a vasodilator, decreases systemic vascular resistance (afterload), reducing the pressure gradient driving the regurgitant flow back into the left ventricle.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Esmolol (beta-blocker) continuous IV infusion titrated to a heart rate of 60&ndash;70 beats/min: </span></strong><span style=\"font-size:12.0pt\">Slowing the heart rate increases diastolic time, worsening regurgitation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Intra-aortic balloon pump:</span></strong><span style=\"font-size:12.0pt\"> Contraindicated in severe aortic regurgitation, as it inflates during diastole, further increasing regurgitation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> <strong>IV norepinephrine</strong>: IV norepinephrine and E. Vasopressin: These are vasopressors that increase afterload, which would worsen aortic regurgitation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In acute severe aortic regurgitation with cardiogenic shock, IV nitroprusside can be used as a bridge to surgery by reducing afterload and improving forward flow.</span></span></span></p>",
      "correct_choice_id": 214435,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53748,
      "choices": [
        {
          "id": 214465,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral stenosis </span></span></p>"
        },
        {
          "id": 214466,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic stenosis </span></span></p>"
        },
        {
          "id": 214467,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral regurgitation </span></span></p>"
        },
        {
          "id": 214468,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic regurgitation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old female presented with fatigue. Cardiac catheterization is done and it is demonstrated below. What is the diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-140418.jpg\" style=\"height:283px; width:400px\" /></span></span></p>",
      "unique_key": "Q3790326",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391906,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">A) Mitral stenosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image shows a characteristic pressure tracing of mitral stenosis. The key features that point towards this diagnosis are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Elevated left atrial pressure (LA)</span></strong><span style=\"font-size:12.0pt\">: The red line (LA pressure) is significantly higher than the left ventricular pressure (LV pressure) during diastole. This indicates a pressure gradient across the mitral valve, suggesting stenosis (narrowing).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diastolic pressure gradient</span></strong><span style=\"font-size:12.0pt\">: The shaded area between the LA and LV pressure curves during diastole represents the pressure gradient across the mitral valve. In mitral stenosis, this gradient is elevated.</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Aortic stenosis</span></strong><span style=\"font-size:12.0pt\">: This would show a pressure gradient between the left ventricle and the aorta during systole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mitral regurgitation</span></strong><span style=\"font-size:12.0pt\">: This would show a high-pressure V wave in the left atrial pressure tracing during systole, due to blood regurgitating back into the left atrium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aortic regurgitation</span></strong><span style=\"font-size:12.0pt\">: This would show an elevated left ventricular diastolic pressure and a rapid decline in aortic pressure during diastole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">LA-LV gradient during diastole is characteristic of mitral stenosis. </span></span></span></p>",
      "correct_choice_id": 214465,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53752,
      "choices": [
        {
          "id": 214481,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral stenosis</span></span></p>"
        },
        {
          "id": 214482,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic stenosis</span></span></p>"
        },
        {
          "id": 214483,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitral regurgitation </span></span></p>"
        },
        {
          "id": 214484,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic regurgitation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man presented with chest pain. Cardiac catheterization is done and it is demonstrated below. What is the diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-140521.jpg\" style=\"height:359px; width:300px\" /></span></span></p>",
      "unique_key": "Q5140110",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391907,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Aortic stenosis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The key finding in the image is a significant pressure gradient between the left ventricle (LV) and the aorta during systole. This pressure gradient indicates that the blood flow from the LV to the aorta is obstructed, which is a hallmark of LVOT obstruction like aortic stenosis. Common symptoms of aortic stenosis include chest pain, syncope and dyspnea (especially during exertion). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Mitral stenosis</span></strong><span style=\"font-size:12.0pt\">: This would show a pressure gradient between the left atrium and left ventricle during diastole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mitral regurgitation</span></strong><span style=\"font-size:12.0pt\">: This would show a high-pressure V wave in the left atrial pressure tracing during systole, due to blood regurgitating back into the left atrium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aortic regurgitation</span></strong><span style=\"font-size:12.0pt\">: This would show an elevated left ventricular diastolic pressure and a rapid decline in aortic pressure during diastole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">:</span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The pressure gradient between the LV and the aorta during systole is hallmark of LVOT obstruction (like aortic stenosis).</span></span></span></p>",
      "correct_choice_id": 214482,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54167,
      "choices": [
        {
          "id": 216137,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Another bolus of atropine </span></span></span></p>"
        },
        {
          "id": 216138,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">IV Norepinephrine </span></span></span></p>"
        },
        {
          "id": 216139,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">IV Dopamine</span></span></span></p>"
        },
        {
          "id": 216140,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IV Dobutamine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old male with recent post-CABG (coronary artery bypass graft) status presents with chest pain. On arrival, his blood pressure is 60/30 mmHg with a heart rate of 30/min. The ECG shows a narrow complex arrhythmia. The patient has already received three boluses of IV atropine. While awaiting transcutaneous pacing, which of the following is the next appropriate step in management?</span></span></p>",
      "unique_key": "Q2925354",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391908,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) IV Dopamine</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is experiencing symptomatic bradycardia (low heart rate) with severe hypotension, likely due to a post-operative complication. The maximum dose of atropine has already been given with no adequate response. The next best step is cardiac pacing. But while awaiting pacing, one can try chronotropic drugs like dopamine, epinephrine in the ER. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Another bolus of atropine:</span></strong><span style=\"font-size:12.0pt\"> As per ACLS guidelines, a maximum of three boluses of atropine are recommended for symptomatic bradycardia. Further doses are unlikely to be effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. IV Norepinephrine:</span></strong><span style=\"font-size:12.0pt\"> While norepinephrine is a potent vasopressor, it can also worsen bradycardia due to its reflex bradycardia effect (baroreceptor response).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Opion D. IV Dobutamine:</span></strong><span style=\"font-size:12.0pt\"> Dobutamine primarily acts on beta-1 receptors, increasing heart rate and contractility, but it can also cause vasodilation (beta-2 effects), potentially worsening hypotension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronotropic drugs like dopamine can be tried while awaiting pacing in symptomatic bradycardia with hypotension, especially when atropine has been ineffective. </span></span></span></p>",
      "correct_choice_id": 216139,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54168,
      "choices": [
        {
          "id": 216141,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiac magnetic resonance perfusion scan </span></span></span></p>"
        },
        {
          "id": 216142,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coronary CT angiography </span></span></span></p>"
        },
        {
          "id": 216143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SPECT MPI </span></span></span></p>"
        },
        {
          "id": 216144,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Exercise echocardiography</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following non-invasive tests has the best accuracy in detecting coronary stenosis?</span></span></p>",
      "unique_key": "Q5605081",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391909,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Coronary CT angiography</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Accuracy in diagnostic tests is often determined by considering both sensitivity and specificity. Coronary CT angiography is the most accurate as it has the highest sensitivity and specificity. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-091702.png\" style=\"height:355px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. CMR perfusion</span></strong><span style=\"font-size:12.0pt\"> have high sensitivity, but their specificity is not as high as Coronary CTA, meaning they might produce more false-positive results.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Exercise echocardiography</span></strong><span style=\"font-size:12.0pt\"> and </span><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12.0pt\"><strong>C.&nbsp;SPECT MPI</strong> have lower sensitivity and specificity than Coronary CTA, indicating a higher chance of both false negatives and false positives.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coronary CTA is a highly accurate non-invasive test for detecting coronary stenosis due to its excellent sensitivity and specificity. It is a valuable tool for diagnosing and evaluating CAD.</span></span></span></p>",
      "correct_choice_id": 216142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54171,
      "choices": [
        {
          "id": 216153,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenosine 6 mg IV </span></span></span></p>"
        },
        {
          "id": 216154,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carotid body massage </span></span></span></p>"
        },
        {
          "id": 216155,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Metoprolol 5 mg IV </span></span></span></p>"
        },
        {
          "id": 216156,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Valsalva maneuver</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 46-year-old man with bacterial pneumonia experiences a sudden lightheadedness. His BP is stable, and the rhythm strip is shown. Which of the following is most likely to lead to sustained improvement in heart rate?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-182921.png\" style=\"height:108px; width:400px\" /></span></span></p>",
      "unique_key": "Q6519677",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391910,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Metoprolol 5 mg IV</strong> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient has focal atrial tachycardia. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Focal atrial tachycardia (FAT) accounts for ~10% of PSVTs in patients referred for catheter ablation (most common is AVNRT responsible for ~60% of PSVTs).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The arrows (which are a nice clue in the question!) indicate the ectopic atrial activity. While one could consider that this might be sinus tachycardia, the rate far exceeds the patient&rsquo;s maximal predicted heart rate (220 &ndash; age) and obviates the possibility of any sinus rhythm. Any maneuver or pharmacologic therapy aimed at producing transient atrioventricular (AV) nodal block (e.g., Valsalva, carotid massage, adenosine) may briefly slow the ventricular response. However, since focal atrial tachycardia does not rely on the AV node for continuation it is rare that transient AV nodal block will terminate the arrhythmia. Beta blockers or non-dihydropyridine calcium channel blockers can lead to sustained improvement in heart rate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Adenosine 6 mg IV</span></strong><span style=\"font-size:12.0pt\">: Primarily used for supraventricular tachycardia (SVT) and may not be effective in FAT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Carotid body massage</span></strong><span style=\"font-size:12.0pt\">: A vagal maneuver that may temporarily slow the heart rate but is not a definitive treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Valsalva maneuver</span></strong><span style=\"font-size:12.0pt\">: A vagal maneuver that may temporarily slow the heart rate but is not a definitive treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Focal atrial tachycardia is not dependent on the AV node and beta-blockers or non-dihydropyridine CCBs are the preferred treatment options for rate control. </span></span></span></p>",
      "correct_choice_id": 216155,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54172,
      "choices": [
        {
          "id": 216157,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calcium ryanodine receptor </span></span></span></p>"
        },
        {
          "id": 216158,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Desmosomal proteins </span></span></span></p>"
        },
        {
          "id": 216159,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Potassium channel </span></span></span></p>"
        },
        {
          "id": 216160,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Sarcomere proteins</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are called to the ER for a young patient in cardiac arrest during exercise. ECG showed bidirectional VT and it was cardioverted immediately. ECG post-cardioversion is normal. 2D Echo and cardiac MRI are also normal. Mutations in which protein are responsible for this?</span></span></p>",
      "unique_key": "Q6165127",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391911,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Calcium ryanodine receptor</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s young age, cardiac arrest during exercise (with bidirectional VT), normal resting ECG and normal structural heart on imaging strongly suggest CPVT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Desmosomal proteins:</span></strong><span style=\"font-size:12.0pt\"> Mutations in desmosomal proteins cause arrhythmogenic right ventricular cardiomyopathy (ARVC), which is a structural heart disease. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Potassium channel:</span></strong><span style=\"font-size:12.0pt\"> Mutations in potassium channels can cause long QT syndrome. In this case resting ECG would have showed long QTc. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Sarcomere proteins:</span></strong><span style=\"font-size:12.0pt\"> Mutations in sarcomere proteins cause hypertrophic cardiomyopathy (HCM), which would have resulted in structural heart disease. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recognize bidirectional VT as a hallmark of CPVT, an inherited arrhythmia syndrome caused by mutations in the cardiac ryanodine receptor (RyR2).</span></span></span></p>",
      "correct_choice_id": 216157,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54176,
      "choices": [
        {
          "id": 216173,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Two anginal episode in 24 hours. </span></span></span></p>"
        },
        {
          "id": 216174,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Age. </span></span></span></p>"
        },
        {
          "id": 216175,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Daily aspirin use. </span></span></span></p>"
        },
        {
          "id": 216176,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the above confer increased risk.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are seeing a 75-year-old man admitted for non-ST-elevation myocardial infarction. He has a history of CAD and takes daily aspirin. He&#39;s had multiple angina episodes in the past few days, has ST-segment depression on ECG, and elevated troponin. Which of the following details does NOT confer increased risk of poor outcomes?</span></span></p>",
      "unique_key": "Q2058178",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391912,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) All of the above confer increased risk</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patients with documented non&ndash;ST-elevation acute coronary syndrome (ACS) exhibit a wide spectrum of early (30 days) risk of death, ranging from 1 to 10%, and a recurrent ACS rate of 5&ndash;15% during the first year. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Assessment of risk can be accomplished by clinical risk scoring systems such as that developed from the Thrombolysis in Myocardial Infarction (TIMI) Trials, which includes seven independent risk factors (age &ge;65 years, 3 or more of the traditional risk factors for CAD, known history of CAD or coronary stenosis &ge; 50%, daily aspirin use in the prior week, more than one anginal episode in the past 24 hours, ST-segment deviation of at least 0.5 mm, and an elevated cardiac specific biomarker above the upper limit of normal). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Additional risk factors include diabetes, LV dysfunction, renal dysfunction, and elevated BNP. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Explanation</u>:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Two anginal episode in 24 hours</span></strong><span style=\"font-size:12.0pt\">: High risk indicating loss of ischemic preconditioning and an active/ongoing ischemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Age</span></strong><span style=\"font-size:12.0pt\">: Advanced age is the SINGLE most important risk factor in ACS.&nbsp; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Daily aspirin use</span></strong><span style=\"font-size:12.0pt\">: While aspirin is cardioprotective, ACS despite use of aspirin indicates high thrombus burden and hence, high risk. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TIMI score for NSTE-ACS is important!</span></span></span></p>",
      "correct_choice_id": 216176,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6670,
      "choices": [
        {
          "id": 26649,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CT angiography </span></span></span></p>"
        },
        {
          "id": 26650,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis and admission to a telemetry bed </span></span></span></p>"
        },
        {
          "id": 26651,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis and transfer to a PCI center </span></span></span></p>"
        },
        {
          "id": 26652,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transfer to a tertiary care center</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old man presents with an chest pain, nausea and diaphoresis. ECG is shown. The nearest tertiary care center is 140 minutes away. What is the most appropriate management?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-102708.png\" style=\"height:227px; width:400px\" /></span></span></p>",
      "unique_key": "Q4247628",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391913,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Thrombolysis and transfer to a PCI center</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When primary PCI cannot be performed within 120 minutes of first medical contact (FMC), thrombolytic therapy is recommended for STEMI patients. While undergoing thrombolysis, the patient should be transferred to a PCI center for further evaluation and potential rescue PCI if needed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. CT angiography</span></strong><span style=\"font-size:12.0pt\">: Delays reperfusion therapy, which is crucial in STEMI. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Thrombolyse and admit</span></strong><span style=\"font-size:12.0pt\">: Does not allow for timely angiography and potential rescue PCI. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Transfer to tertiary care center</span></strong><span style=\"font-size:12.0pt\">: Delays reperfusion and worsens outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For patients with STEMI, thrombolytic therapy is recommended if symptom onset is within 12 hours and PPCI is not available within 120 minutes of FMC.</span></span></span></p>",
      "correct_choice_id": 26651,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6673,
      "choices": [
        {
          "id": 26661,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atropine </span></span></span></p>"
        },
        {
          "id": 26662,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tenecteplase </span></span></span></p>"
        },
        {
          "id": 26663,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary Angioplasty</span></span></span></p>"
        },
        {
          "id": 26664,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Temporary pacing</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 73-year-old woman presents with severe chest pain for the last 3 hours. She is diaphoretic and appears drowsy. Her BP is 80/60 mm Hg and PR is 60/min. ECG is shown below. She was started on aspirin, clopidogrel and heparin. What is the next step?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-102907.png\" style=\"height:222px; width:400px\" /></span></span></p>",
      "unique_key": "Q5848565",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391914,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Temporary pacing</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient is presenting with an acute anterior MI complicated by cardiogenic shock and high-grade AV block (Mobitz II).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The immediate priority in this situation is to stabilize the patient&#39;s hemodynamic status and address the conduction abnormality. Temporary pacing is the most appropriate next step to provide electrical support and maintain adequate cardiac output until definitive revascularization can be performed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Atropine:</span></strong><span style=\"font-size:12.0pt\"> Atropine may be useful for bradycardia but is unlikely to be effective in the setting of high-grade AV block. Additionally, it does not address the underlying myocardial ischemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tenecteplase:</span></strong><span style=\"font-size:12.0pt\"> While fibrinolysis with tenecteplase may be considered in some STEMI cases, it is not the first-line therapy in this case. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Primary Angioplasty:</span></strong><span style=\"font-size:12.0pt\"> Primary PCI is the preferred reperfusion strategy for STEMI, but it should be performed after stabilizing the patient&#39;s hemodynamics with temporary pacing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anterior<strong> </strong>MI related bradyarrhythmias are inherently unstable and need temporary pacing. </span></span></span></p>",
      "correct_choice_id": 26664,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6675,
      "choices": [
        {
          "id": 26669,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Digoxin </span></span></span></p>"
        },
        {
          "id": 26670,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intra-aortic balloon pump (IABP) placement</span></span></span></p>"
        },
        {
          "id": 26671,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metoprolol </span></span></span></p>"
        },
        {
          "id": 26672,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urgent cardiac transplantation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 71-year-old woman presents with cardiogenic shock. ECG showed ST depressions in multiple leads and her Troponins were elevated. PCI was performed successfully but she continues to be in cardiogenic shock and she is on aspirin, prasugrel and norepinephrine. Which of the following is the most appropriate additional management?</span></span></p>",
      "unique_key": "Q9704389",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391915,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Intra-aortic balloon pump (IABP) placement</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of cardiogenic shock initially focuses on reversing the cause of shock, such as reperfusion in the setting of acute coronary syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In cardiogenic shock, appropriate therapies to support cardiac output include inotropes, vasopressors, and mechanical support (such as balloon pumps, percutaneous ventricular assist devices, and extracorporeal membrane oxygenation).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Digoxin</span></strong><span style=\"font-size:12.0pt\">: Weak inotrope, unlikely to be effective in cardiogenic shock. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Metoprolol</span></strong><span style=\"font-size:12.0pt\">: Beta-blocker, contraindicated in cardiogenic shock due to negative inotropic effects. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Urgent cardiac transplantation</span></strong><span style=\"font-size:12.0pt\">: Not feasible in the acute setting. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IABP is a mechanical circulatory support device that can temporarily improve hemodynamics in patients with cardiogenic shock after MI by reducing afterload and improving coronary perfusion.</span></span></span></p>",
      "correct_choice_id": 26670,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6682,
      "choices": [
        {
          "id": 26697,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aspirin plus clopidogrel </span></span></span></p>"
        },
        {
          "id": 26698,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aspirin plus ticagrelor</span></span></span></p>"
        },
        {
          "id": 26699,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aspirin plus rivaroxaban plus ticagrelor</span></span></span></p>"
        },
        {
          "id": 26700,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rivaroxaban plus ticagrelor</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 69-year-old woman with a history of NSTEMI and AF underwent a successful PCI with a drug eluting stent. What is the most appropriate management of her antithrombotic therapy?</span></span></p>",
      "unique_key": "Q3000601",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391916,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Rivaroxaban plus ticagrelor</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The AUGUSTUS trial demonstrated that dual therapy with a direct oral anticoagulant (DOAC) like rivaroxaban and a P2Y12 inhibitor like ticagrelor resulted in lower bleeding rates without an increase in ischemic events (when compared with triple therapy - DOAC + aspirin + P2Y12 inhibitor) in patients with atrial fibrillation (AF) undergoing PCI. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aspirin plus clopidogrel:</span></strong><span style=\"font-size:12.0pt\"> This is traditional dual antiplatelet therapy (DAPT) and does not address the need for anticoagulation in AF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Aspirin plus ticagrelor:</span></strong><span style=\"font-size:12.0pt\"> Similar to option a, it lacks anticoagulation for AF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Aspirin plus rivaroxaban plus ticagrelor:</span></strong><span style=\"font-size:12.0pt\"> Triple therapy is no longer recommended as it increases bleeding risk without significant additional benefit compared to dual therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Among patients with atrial fibrillation who have undergone percutaneous coronary intervention for acute coronary syndrome, double therapy with clopidogrel or ticagrelor plus a direct oral anticoagulant is recommended over triple therapy with an oral anticoagulant, aspirin, and P2Y12 inhibitor to reduce the risk for bleeding.</span></span></span></p>",
      "correct_choice_id": 26700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6685,
      "choices": [
        {
          "id": 26709,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recurrent MI</span></span></span></p>"
        },
        {
          "id": 26710,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Early Pericarditis</span></span></span></p>"
        },
        {
          "id": 26711,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dressler&#39;s Syndrome</span></span></span></p>"
        },
        {
          "id": 26712,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe GERD due to aspirin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 51-year-old male presents with chest pain, 4 days after he was diagnosed with an ST elevation myocardial infarction (STEMI). It is severe, central chest pain with radiation to the trapezius and worse with deep inspiration. The pain woke him from sleep and has improved slightly after getting up out of bed. His Troponin levels were unchanged and ECG showed new saddle-shaped ST elevations in inferior and lateral leads. What is the likely cause?</span></span></p>",
      "unique_key": "Q8176879",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391917,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Early Pericarditis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation is most consistent with early pericarditis, which is a common complication of STEMI occurring within the first few days after the infarction. The typical features include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chest pain:</span></strong><span style=\"font-size:12.0pt\"> Sharp, pleuritic (worse with inspiration), and positional (relieved by sitting up or leaning forward).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">ECG changes:</span></strong><span style=\"font-size:12.0pt\"> Diffuse ST-segment elevation with a concave or saddle-shaped morphology.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Unchanged troponin:</span></strong><span style=\"font-size:12.0pt\"> Troponin levels are usually not elevated in pericarditis, as it is an inflammatory process and not a myocardial infarction.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Recurrent MI:</span></strong><span style=\"font-size:12.0pt\"> While possible, the unchanged troponin and the specific characteristics of the chest pain make it less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Dressler&#39;s Syndrome:</span></strong><span style=\"font-size:12.0pt\"> This is a post-MI syndrome occurring weeks to months after the infarction, characterized by fever, pericarditis, pleuritis, and leukocytosis. It is too early for this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Severe GERD due to aspirin:</span></strong><span style=\"font-size:12.0pt\"> GERD can cause chest pain, but the pain is typically burning and not pleuritic. Additionally, the ECG changes are not consistent with GERD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Early pericarditis is a common complication of STEMI that typically occurs in the first week after MI. </span></span></span></p>",
      "correct_choice_id": 26710,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6608,
      "choices": [
        {
          "id": 26401,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amiodarone </span></span></span></p>"
        },
        {
          "id": 26402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Genetic testing </span></span></span></p>"
        },
        {
          "id": 26403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Implantable cardioverter-defibrillator (ICD) </span></span></span></p>"
        },
        {
          "id": 26404,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lisinopril</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 18-year-old athlete experiences cardiac arrest during a race and is successfully resuscitated. Resting ECG is shown. Echocardiogram shows normal LV function but RV dilation and dysfunction. What is the most appropriate management before discharge?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-115610.jpg\" style=\"height:207px; width:500px\" /></span></span></p>",
      "unique_key": "Q2742687",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391918,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C) Implantable cardioverter-defibrillator (ICD)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sudden cardiac arrest with &lsquo;&epsilon;&rsquo; wave in ECG and RV dysfunction in echo in young athletes raises suspicion for underlying inherited cardiomyopathies, like arrhythmogenic right ventricular cardiomyopathy (ARVC). An ICD is the most appropriate intervention to prevent sudden cardiac death due to arrhythmias. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Amiodarone:</span></strong><span style=\"font-size:12.0pt\"> Antiarrhythmic medication, but not as effective as ICD for preventing sudden death. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Genetic testing:</span></strong><span style=\"font-size:12.0pt\"> Important for diagnosis and family screening, but not the immediate priority before discharge.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Lisinopril:</span></strong><span style=\"font-size:12.0pt\"> ACE inhibitor for LV dysfunction, not indicated in this case with normal LV function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patients with sustained ventricular arrhythmias (&gt;30 seconds) or cardiac arrest without a reversible cause have a class 1 recommendation for secondary prevention with implantable cardioverter-defibrillator placement.</span></span></span></p>",
      "correct_choice_id": 26403,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6609,
      "choices": [
        {
          "id": 26405,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac MRI </span></span></p>"
        },
        {
          "id": 26406,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exercise echocardiography </span></span></p>"
        },
        {
          "id": 26407,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right and left heart catheterization </span></span></p>"
        },
        {
          "id": 26408,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum &alpha;-galactosidase level</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man presents with ascites, pedal edema and elevated JVP. ECG showed low voltage complexes and echo showed increased LV wall thickness. He also has a history of carpal tunnel syndrome. What is the most appropriate test?</span></span></p>",
      "unique_key": "Q2768512",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391919,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Cardiac MRI</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of heart failure, increased wall thickness, low voltage on ECG, and carpal tunnel syndrome raises suspicion for infiltrative cardiomyopathy, like transthyretin amyloid (ATTR) amyloidosis. CMR with gadolinium is the most sensitive and specific test for diagnosing cardiac amyloidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Exercise echocardiography:</span></strong><span style=\"font-size:12.0pt\"> Primarily used to diagnose coronary artery disease. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Right and left heart catheterization:</span></strong><span style=\"font-size:12.0pt\"> Invasive and not the first-line test for infiltrative cardiomyopathy. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Serum &alpha;-galactosidase level:</span></strong><span style=\"font-size:12.0pt\"> Used to diagnose Fabry disease, which usually causes Hypertrophic Cardiomyopathy. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiac magnetic resonance imaging with gadolinium is highly sensitive and specific for cardiac amyloidosis, but it does not distinguish between AL (immunoglobulin light-chain) amyloidosis and transthyretin amyloidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with cardiac magnetic resonance imaging findings consistent with cardiac amyloidosis, an abnormal 99m-technetium pyrophosphate scan would confirm transthyretin amyloidosis without the need for a biopsy.</span></span></p>",
      "correct_choice_id": 26405,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6611,
      "choices": [
        {
          "id": 26413,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute pulmonary embolism</span></span></span></p>"
        },
        {
          "id": 26414,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ascending aortic dissection </span></span></span></p>"
        },
        {
          "id": 26415,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Peripartum cardiomyopathy </span></span></span></p>"
        },
        {
          "id": 26416,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spontaneous coronary artery dissection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 8-day postpartum woman presents with acute heart failure symptoms. Echocardiogram shows LV dilation and hypokinesis with an ejection fraction of 38%.RV is normal. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q8366476",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391920,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C) Peripartum cardiomyopathy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Peripartum cardiomyopathy is characterized by the development of heart failure in the last month of pregnancy or within 5 months postpartum. The presentation of LV dysfunction with no other identifiable cause fits this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Acute pulmonary embolism</span></strong><span style=\"font-size:12.0pt\">: Less likely given normal right heart function on echocardiogram. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B. Ascending aortic dissection:</strong> Usually presents with acute chest pain, and echo would show aortic abnormalities. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D. Spontaneous coronary artery dissection:</strong> Typically presents with chest pain and ECG changes indicative of ischemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peripartum cardiomyopathy is left ventricular systolic dysfunction with onset toward the end of pregnancy or in the months after delivery in the absence of another identifiable cause; patients often present with features of heart failure.</span></span></p>",
      "correct_choice_id": 26415,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6613,
      "choices": [
        {
          "id": 26421,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Digoxin </span></span></span></p>"
        },
        {
          "id": 26422,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heart transplantation </span></span></span></p>"
        },
        {
          "id": 26423,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left ventricular assist device (LVAD) placement </span></span></span></p>"
        },
        {
          "id": 26424,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tolvaptan</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old man with ischemic cardiomyopathy (EF 20%) is on maximally tolerated heart failure medications and experiencing significant functional decline. He wishes to pursue care that will restore functionality. What is the most appropriate long-term treatment?</span></span></p>",
      "unique_key": "Q9379264",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391921,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Heart transplantation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heart transplantation is the most appropriate long-term treatment for patients with advanced heart failure who have persistent severe symptoms despite optimal medical therapy. It can significantly improve quality of life and survival in suitable candidates. This patient&#39;s young age (56 years old) and desire for functional improvement make him a potential candidate for transplantation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Digoxin:</span></strong><span style=\"font-size:12.0pt\"> Although it can reduce hospitalizations, it does not improve survival or functional capacity. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. LVAD placement:</span></strong><span style=\"font-size:12.0pt\"> LVADs are a bridge to transplantation or destination therapy for those who are not transplant candidates. This patient may be eligible for transplant. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tolvaptan:</span></strong><span style=\"font-size:12.0pt\"> Used for hyponatremia, but not a primary treatment for advanced heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with persistent severe heart failure symptoms despite maximal medical therapy are candidates for advanced treatment; acceptable candidates for cardiac transplantation are generally younger than 65 to 70 years with no medical contraindications and have good social support and adherence.</span></span></p>",
      "correct_choice_id": 26422,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6614,
      "choices": [
        {
          "id": 26425,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Add eplerenone</span></span></span></p>"
        },
        {
          "id": 26426,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Add ivabradine </span></span></span></p>"
        },
        {
          "id": 26427,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Switch carvedilol to metoprolol succinate </span></span></span></p>"
        },
        {
          "id": 26428,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Switch losartan to valsartan-sacubitril</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 47-year-old man with a history of HFrEF and AF, presents for follow-up with stable NYHA class III symptoms. He is currently on losartan, carvedilol, empagliflozin, furosemide, and apixaban. He has a history of ACE inhibitor-induced angioedema and spironolactone-induced gynecomastia. Which medication is the most appropriate addition to his current regimen?</span></span></p>",
      "unique_key": "Q3070788",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391922,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Add eplerenone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eplerenone, a selective aldosterone antagonist, is indicated in patients with symptomatic HFrEF and normal kidney function to improve survival. This patient has normal renal function and has not tolerated spironolactone due to gynecomastia. Eplerenone is a suitable alternative as it has a lower risk of endocrine side effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Ivabradine:</span></strong><span style=\"font-size:12.0pt\"> Not indicated in patients with atrial fibrillation. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Switch carvedilol to metoprolol succinate:</span></strong><span style=\"font-size:12.0pt\"> Not necessary, as there is no evidence of <strong>benefit in switching between beta-blockers in this scenario. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Switch losartan to valsartan-sacubitril:</span></strong><span style=\"font-size:12.0pt\"> Contraindicated due to the history of ACE inhibitor-induced angioedema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aldosterone antagonist therapy (spironolactone, eplerenone) is indicated in all patients with symptomatic heart failure with reduced ejection fraction and normal kidney function to improve survival.</span></span></span></p>",
      "correct_choice_id": 26425,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7080,
      "choices": [
        {
          "id": 28288,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrioventricular (AV) node ablation with permanent pacemaker implantation</span></span></span></p>"
        },
        {
          "id": 28289,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Implantable cardioverter-defibrillator (ICD) placement </span></span></span></p>"
        },
        {
          "id": 28290,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left atrial appendage occlusion (LAAO)</span></span></span></p>"
        },
        {
          "id": 28291,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rhythm control</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old woman with paroxysmal AF and HFrEF (EF 45%) has recurrent hospitalizations due to acute heart failure. She is currently on apixaban, metoprolol, furosemide, and telmisartan. What is the most appropriate treatment?</span></span></span></p>",
      "unique_key": "Q8695744",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391923,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) Rhythm control</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aggressive rhythm control (with antiarrhythmic drugs or catheter ablation) has been shown to reduce morbidity and mortality in patients with HF and AF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with HFrEF, recent clinical trials have shown that catheter ablation of AF is associated with a favorable effect on morbidity and mortality compared with medical therapy. Amiodarone is another option for rhythm control. Although amiodarone carries a risk for toxicity, this patient&#39;s lifetime exposure to the drug is likely to be relatively low given her age, comorbid conditions, and probable amiodarone dosage, which is generally lower for AF than for ventricular arrhythmias. Monitored appropriately, it can be used safely and effectively in patients her age.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. AV node ablation:</span></strong><span style=\"font-size:12.0pt\"> Considered only if rate and rhythm control fails to control tachycardia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. ICD:</span></strong><span style=\"font-size:12.0pt\"> Indicated for primary prevention of sudden cardiac death in certain patients, but not the primary treatment for this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. LAAO:</span></strong><span style=\"font-size:12.0pt\"> Used for stroke prevention in patients who have C/I for anticoagulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aggressive efforts to achieve rhythm control in patients with atrial fibrillation and concomitant heart failure decrease morbidity and mortality.</span></span></p>",
      "correct_choice_id": 28291,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7083,
      "choices": [
        {
          "id": 28300,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic stenosis</span></p>"
        },
        {
          "id": 28301,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac tamponade</span></p>"
        },
        {
          "id": 28302,
          "text": "<p><span style=\"font-size:12.0pt;\">Heart failure with reduced ejection fraction</span></p>"
        },
        {
          "id": 28303,
          "text": "<p><span style=\"font-size:12.0pt;\">Large pericardial effusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 69-year-old woman is evaluated in the emergency department for a 1-week history of progressive exertional dyspnea and orthopnea. Vital signs are normal. Focused point-of-care cardiac ultrasonography is performed and done and as shown below. Which of the following is the most likely&nbsp;diagnosis?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/supawork-e53ff9bb04dd417abdf7b818ed4326bc.gif\" width=\"600\" height=\"406\"></p>",
      "unique_key": "Q4189323",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391924,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Heart failure with reduced ejection fraction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Heart failure with reduced ejection fraction (HFrEF) is characterized by a reduced left ventricular ejection fraction (LVEF), typically &lt;40%, as seen in the ultrasonographic findings. Symptoms such as progressive exertional dyspnea and orthopnea are hallmark clinical manifestations of left-sided heart failure, commonly due to impaired myocardial contractility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aortic stenosis</strong>: Aortic stenosis typically presents with symptoms such as chest pain, syncope, and heart failure. However, the ultrasound findings do not suggest aortic valve pathology or significant left ventricular outflow obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cardiac tamponade</strong>: Cardiac tamponade would present with findings such as hypotension, jugular venous distension, and pulsus paradoxus. The ultrasound in tamponade typically shows a large pericardial effusion with diastolic collapse of the right atrium or right ventricle. These findings are not present in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Large pericardial effusion</strong>: A large pericardial effusion would show a significant fluid accumulation around the heart on ultrasound, often leading to tamponade physiology. This is not observed in the provided ultrasound image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize the clinical presentation of heart failure with reduced ejection fraction (HFrEF) and correlate it with echocardiographic findings, emphasizing the importance of identifying left ventricular systolic dysfunction in patients presenting with symptoms of heart failure.</span></p>",
      "correct_choice_id": 28302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7087,
      "choices": [
        {
          "id": 28316,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Cardiac tamponade</span></span></span></p>"
        },
        {
          "id": 28317,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Eosinophilic pneumonia</span></span></span></p>"
        },
        {
          "id": 28318,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lymphangioleiomyomatosis</span></span></span></p>"
        },
        {
          "id": 28319,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary edema</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man is evaluated in the emergency department for acute worsening of dyspnea. Chest radiograph is shown. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-115748.jpg\" style=\"height:370px; width:400px\" /></span></span></p>",
      "unique_key": "Q4234359",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391925,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) Pulmonary edema</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient&#39;s chest radiograph shows cardiomegaly and bilateral perihilar alveolar infiltrates, consistent with a diagnosis of pulmonary edema due to heart failure. A small left pleural effusion is seen, as well as fluid in the minor fissure, also consistent with heart failure. Although cardiomegaly can be seen in tamponade, diffuse alveolar infiltrates are not a feature of this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cardiac tamponade</span></strong><span style=\"font-size:12.0pt\">: While cardiomegaly can be seen in cardiac tamponade, which is a condition where fluid accumulates in the sac surrounding the heart, leading to compression of the heart, diffuse alveolar infiltrates are not a feature of cardiac tamponade. Therefore, this diagnosis is unlikely based on the radiographic findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Eosinophilic pneumonia</span></strong><span style=\"font-size:12.0pt\">: Eosinophilic pneumonia is characterized by the presence of eosinophils (a type of white blood cell) in the lung tissue, which typically presents with bilateral infiltrates on a chest radiograph. However, this condition does not usually present with cardiomegaly or pleural effusion, making this option less likely given the findings on the radiograph.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C. Lymphangioleiomyomatosis:</strong> Lymphangioleiomyomatosis is a rare lung disease that affects the lungs and lymphatic system, leading to cystic lung disease. The chest radiograph for this condition would typically show diffuse thin-walled cysts rather than cardiomegaly, alveolar infiltrates, or pleural effusion. Thus, this diagnosis is inconsistent with the radiographic findings in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary edema is characterized by cardiomegaly and bilateral perihilar alveolar infiltrates on a chest radiograph, often associated with pleural effusion and fluid in the minor fissure, especially in the context of heart failure. This is a key diagnostic feature that must be remembered.</span></span></span></p>",
      "correct_choice_id": 28319,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7088,
      "choices": [
        {
          "id": 28320,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stage A </span></span></span></p>"
        },
        {
          "id": 28321,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stage B </span></span></span></p>"
        },
        {
          "id": 28322,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stage C </span></span></span></p>"
        },
        {
          "id": 28323,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stage D</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 68-year-old man with a past medical history of coronary artery disease develops a myocardial infarction. He got treated in CCU and before he is discharged, he undergoes echocardiography, which reveals a left ventricular ejection fraction of 35% to 40%. He is asymptomatic. Repeat Echo after 3 months shows the same findings. What is this patient&rsquo;s heart failure stage?</span></span></span></p>",
      "unique_key": "Q6574719",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391926,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Stage B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient has structural heart disease (reduced ejection fraction due to prior myocardial infarction) but no current symptoms of heart failure. This places him in <strong>Stage B</strong> heart failure according to the American College of Cardiology/American Heart Association (ACC/AHA) classification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Stage A:</span></strong><span style=\"font-size:12.0pt\"> Patients in Stage A have risk factors for HF but no structural heart disease or symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Stage C:</span></strong><span style=\"font-size:12.0pt\"> Patients in Stage C have structural heart disease and current or prior symptoms of HF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Stage D:</span></strong><span style=\"font-size:12.0pt\"> Patients in Stage D have refractory HF requiring specialized interventions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACC/AHA staging system for heart failure, categorizes patients based on the presence or absence of structural heart disease and symptoms of heart failure. </span></span></p>",
      "correct_choice_id": 28321,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7090,
      "choices": [
        {
          "id": 28328,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Constrictive pericarditis </span></span></span></p>"
        },
        {
          "id": 28329,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fabry disease </span></span></span></p>"
        },
        {
          "id": 28330,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dilated Cardiomyopathy </span></span></span></p>"
        },
        {
          "id": 28331,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Restrictive cardiomyopathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 64-year-old woman with a history of recurrent heart failure hospitalizations presents with ascites and edema. Her JVP was elevated and there was no change with inspiration. On examination, she has an audible low-pitched late diastolic sound with a pansystolic murmur in the left sternal border. Echo shows diastolic dysfunction with mildly increased LV wall thickness. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q2519408",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391927,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) Restrictive cardiomyopathy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ascites and edema:</span></strong><span style=\"font-size:12.0pt\"> These are signs of right heart failure, which can be a consequence of RCM due to increased left atrial pressure.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Elevated JVP with no inspiratory decline:</span></strong><span style=\"font-size:12.0pt\"> This finding, known as Kussmaul&#39;s sign, is suggestive of impaired right ventricular filling, seen in RCM and constrictive pericarditis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Low-pitched late diastolic sound (S4):</span></strong><span style=\"font-size:12.0pt\"> This is a hallmark of RCM and indicates diastolic dysfunction/ stiff ventricle. Patients can have S3 as well. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pansystolic murmur at the left sternal border:</span></strong><span style=\"font-size:12.0pt\"> This suggests tricuspid regurgitation, a common complication of RCM due to right ventricular dilatation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Echo findings:</span></strong><span style=\"font-size:12.0pt\"> Diastolic dysfunction with mildly increased LV wall thickness is typical of RCM.</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Constrictive pericarditis:</span></strong><span style=\"font-size:12.0pt\"> While this can also cause elevated JVP and diastolic dysfunction, it usually does not present with a pansystolic murmur or S3 gallop. Pericardial knock is more characteristic.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Fabry disease:</span></strong><span style=\"font-size:12.0pt\"> This is a rare genetic disorder that can cause RCM, but it is less likely than other causes in this patient without a specific family history or other suggestive features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Dilated cardiomyopathy:</span></strong><span style=\"font-size:12.0pt\"> This presents with systolic dysfunction (reduced ejection fraction) and a dilated left ventricle, which are not seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restrictive cardiomyopathy presents with features of right heart failure, Kussmaul&#39;s sign, S3/S4 gallop, diastolic dysfunction, and associated findings like TR.</span></span></p>",
      "correct_choice_id": 28331,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6578,
      "choices": [
        {
          "id": 26281,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left anterior descending (LAD) artery </span></span></span></p>"
        },
        {
          "id": 26282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left circumflex (LCx) artery </span></span></span></p>"
        },
        {
          "id": 26283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Right coronary artery (RCA) </span></span></span></p>"
        },
        {
          "id": 26284,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left main coronary artery</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man with a history of hypertension and hyperlipidemia presents with acute chest pain radiating to the left arm and jaw. ECG is shown. Which coronary artery is most likely occluded?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-174647.png\" style=\"height:143px; width:400px\" /></span></span></p>",
      "unique_key": "Q6215481",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391928,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Right coronary artery (RCA)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ST-segment elevation in leads II, III, and aVF is indicative of an inferior myocardial infarction, which is most commonly caused by occlusion of the RCA. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(This patient also has ST elevations in V1/V2 which may indicate RV infarction. However V4R is needed to confirm this).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Explanation</u>:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Left anterior descending (LAD) artery</span></strong><span style=\"font-size:12.0pt\">: </span><span style=\"font-size:12.0pt\">Occlusion of the LAD artery typically causes ST-segment elevation in anterior leads. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Left circumflex (LCx) artery</span></strong><span style=\"font-size:12.0pt\">:</span><strong> </strong><span style=\"font-size:12.0pt\">Occlusion of the LCx artery typically causes ST-segment elevation in lateral leads. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Left main coronary artery</span></strong><span style=\"font-size:12.0pt\">: </span><span style=\"font-size:12.0pt\">Occlusion of the left main coronary artery typically causes widespread ST-segment elevation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Educational Objective</u>:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recognize the ECG findings of an inferior myocardial infarction and its association with RCA occlusion.</span></span></span></p>",
      "correct_choice_id": 26283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6581,
      "choices": [
        {
          "id": 26293,
          "text": "<p><span style=\"font-size:12.0pt;\">Synchronized cardioversion</span></p>"
        },
        {
          "id": 26294,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeat adenosine</span></p>"
        },
        {
          "id": 26295,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoptolol</span></p>"
        },
        {
          "id": 26296,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman presents with recurrent palpitations and near-syncope. ECG during the episode is shown. His BP is 130/84 mm Hg and PR is 154/min. Vagal manoeuvrers and IV adenosine (6mg) administration do not terminate the tachycardia. What is the most appropriate next step in management?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-175001.png\" alt=\"\" width=\"400\" height=\"227\"></span></p>",
      "unique_key": "Q9365643",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391929,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Repeat Adenosine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a hemodynamically stable patient with AVNRT, the next step after a failed initial dose of adenosine (6 mg) is to repeat adenosine at a higher dose of 12 mg IV push.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adenosine is a short-acting AV nodal blocker that can effectively terminate AVNRT. The initial dose may not be sufficient in some cases, and a second dose (or even a third dose) is often successful.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Synchronized cardioversion:</strong> This is typically reserved for hemodynamically unstable patients or those who fail medical therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Metoprolol:</strong> Beta-blockers like metoprolol (and calcium channel blockers) are used if initial therapy with vagal manoeuvres and adenosine fail.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amiodarone:</strong> This is an antiarrhythmic drug that can be used if AV nodal blockers fail.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Step wise management of regular narrow complex tachycardia (like AVNRT):</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-175104.png\" alt=\"\" width=\"500\" height=\"540\"></span></p>",
      "correct_choice_id": 26294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6583,
      "choices": [
        {
          "id": 26301,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brugada syndrome </span></span></span></p>"
        },
        {
          "id": 26302,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Congenital long QT syndrome </span></span></span></p>"
        },
        {
          "id": 26303,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Wolff-Parkinson-White syndrome</span></span></span></p>"
        },
        {
          "id": 26304,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertrophic cardiomyopathy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old intern presents with recurrent episodes of syncope after hearing ambulance siren in the ER. She also experiences light-headedness and dizziness early morning once she wakes up hearing alarms. The ECG is shown. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180215.png\" style=\"height:242px; width:400px\" /></span></span></p>",
      "unique_key": "Q1244645",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391930,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Congenital long QT syndrome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Congenital long QT syndrome (LQTS) is a genetic disorder characterized by a prolonged QT interval on the ECG (like in this ECG). LQTS can cause syncope, particularly in response to emotional or auditory stimuli (like the ambulance sirens in this case). This patient&#39;s presentation aligns with LQT2, a subtype of LQTS often triggered by sudden noises.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Brugada syndrome:</span></strong><span style=\"font-size:12.0pt\"> This is associated with a specific ECG pattern (ST-elevation in V1-V3) and sudden cardiac death, not typically triggered by sounds.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Wolff-Parkinson-White syndrome:</span></strong><span style=\"font-size:12.0pt\"> This involves an accessory pathway, causing a short PR interval and delta wave, and is not typically associated with syncope triggered by sound.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hypertrophic cardiomyopathy:</span></strong><span style=\"font-size:12.0pt\"> This is characterized by left ventricular hypertrophy, which may or may not have a prolonged QT interval and is not typically triggered by sound.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syncope triggered by auditory stimuli, combined with a prolonged QT interval on ECG, is highly suggestive of congenital long QT syndrome, particularly LQT2. </span></span></span></p>",
      "correct_choice_id": 26302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6585,
      "choices": [
        {
          "id": 26309,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial fibrillation </span></span></span></p>"
        },
        {
          "id": 26310,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial tachycardia </span></span></span></p>"
        },
        {
          "id": 26311,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrioventricular nodal reentrant tachycardia (AVNRT) </span></span></span></p>"
        },
        {
          "id": 26312,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventricular tachycardia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 42-year-old woman presents with abrupt-onset palpitations that she can terminate by coughing. ECG is shown. What is the most likely rhythm diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180707.png\" style=\"height:211px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q5148909",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391931,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Atrioventricular nodal reentrant tachycardia (AVNRT)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">AVNRT is the most common type of paroxysmal supraventricular tachycardia. It presents with abrupt onset and termination, a narrow QRS complex tachycardia, and often responds to vagal maneuvers like coughing. The pseudo r&#39; wave in V1 is a characteristic ECG finding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180802.png\" style=\"height:170px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Atrial fibrillation:</span></strong><span style=\"font-size:12.0pt\"> Irregular rhythm with no discernible P waves. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Atrial tachycardia:</span></strong><span style=\"font-size:12.0pt\"> Typically slower than AVNRT and less likely to be terminated by vagal maneuvers. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ventricular tachycardia:</span></strong><span style=\"font-size:12.0pt\"> Wide QRS complex tachycardia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;ECG findings of AVNRT = narrow QRS complex tachycardia, pseudo r&#39; wave in V1, and responsiveness to vagal maneuvers. </span></span></span></p>",
      "correct_choice_id": 26311,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6600,
      "choices": [
        {
          "id": 26369,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Accelerated idioventricular rhythm</span></span></span></p>"
        },
        {
          "id": 26370,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left bundle branch block</span></span></span></p>"
        },
        {
          "id": 26371,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Old inferior myocardial infarction</span></span></span></p>"
        },
        {
          "id": 26372,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Right bundle branch block</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 61-year-old man is evaluated following the recent diagnosis of hypertension. ECG is shown. Which of the following abnormalities is seen on this patient&#39;s ECG?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-181851.png\" style=\"height:128px; width:300px\" /></span></span></p>",
      "unique_key": "Q6507737",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391932,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Left bundle branch block</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This ECG demonstrates left bundle branch block. Left bundle branch block is characterized by the following features: (1) QRS widening of at least 120 ms, (2) upright monophasic QRS complex in leads I and V6 (the QRS complex may also be notched), and (3) a predominantly negative QRS complex in lead V1. In the ECG shown, all three features are evident. In both left and right bundle branch block, the ST-T&ndash;wave pattern is inscribed in the opposite direction of the main QRS vectors; these ST-T&ndash;wave abnormalities are secondary to the bundle branch block and do not indicate additional underlying pathology.</span></span></span></p>",
      "correct_choice_id": 26370,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53688,
      "choices": [
        {
          "id": 214225,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial septal defect with shunt reversal</span></span></span></p>"
        },
        {
          "id": 214226,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">D-transposition of the great arteries </span></span></span></p>"
        },
        {
          "id": 214227,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patent ductus arteriosus with shunt reversal</span></span></span></p>"
        },
        {
          "id": 214228,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventricular septal defect with shunt reversal</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An 8-year-old boy from a rural area in tamilnadu presents with fatigue during physical activity, clubbing, and cyanosis in his feet. His hands appear normal. What is the most likely congenital abnormality?</span></span></span></p>",
      "unique_key": "Q9093391",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391933,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Patent ductus arteriosus with shunt reversal</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s differential cyanosis (cyanosis in the lower extremities but not the upper) strongly suggests a patent ductus arteriosus (PDA) with Eisenmenger syndrome. In this condition, pulmonary hypertension develops, reversing the shunt through the PDA and causing deoxygenated blood to flow into the descending aorta.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Atrial septal defect with shunt reversal:</span></strong><span style=\"font-size:12.0pt\"> While ASDs can lead to Eisenmenger syndrome, the cyanosis would be central, affecting both upper and lower extremities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. D-transposition of the great arteries:</span></strong><span style=\"font-size:12.0pt\"> This typically presents with severe central cyanosis (nit differential) shortly after birth, not later in childhood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ventricular septal defect with shunt reversal:</span></strong><span style=\"font-size:12.0pt\"> Similar to ASD, VSDs can lead to Eisenmenger syndrome, but cyanosis would be central, not differential.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Differential cyanosis (lower extremity cyanosis with sparing of the upper extremities) is a hallmark of a PDA with Eisenmenger syndrome.</span></span></span></p>",
      "correct_choice_id": 214227,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53691,
      "choices": [
        {
          "id": 214237,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bicuspid aortic valve with aortic diameter &lt;45 mm </span></span></span></p>"
        },
        {
          "id": 214238,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Partial anomalous pulmonary venous return without pulmonary hypertension </span></span></span></p>"
        },
        {
          "id": 214239,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe native aortic coarctation </span></span></span></p>"
        },
        {
          "id": 214240,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Systemic right ventricle</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following congenital cardiovascular abnormalities would provide the highest maternal risk in the setting of pregnancy?</span></span></p>",
      "unique_key": "Q8907438",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391934,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Severe native aortic coarctation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe native aortic coarctation poses the highest maternal risk during pregnancy due to the increased risk of aortic dissection or rupture. The elevated blood pressure and increased cardiac output during pregnancy can put significant stress on the narrowed aorta. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Risk of cardiac disease and pregnancy is summarised below -</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">WHO Class I:</span></strong><span style=\"font-size:12.0pt\"> MVP, PDA, PS, repaired ASD/VSD, isolated APC/VPC. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">WHO Class II:</span></strong><span style=\"font-size:12.0pt\"> Unrepaired ASD/VSD, repaired TOF, most arrhythmias.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">WHO Class II-III:</span></strong><span style=\"font-size:12.0pt\"> Repaired CoA, HCM, Mild LV dysfunction, Marfan without AoD, BAV + Ao &lt; 4.5cm</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>WHO Class III: </strong>CyCHD, Fontan, systemic RV, Marfan + Ao &ge; 4cm, BAV + Ao &ge; 4.5cm, Mechanical valve</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>WHO Class IV (pregnancy C/I)</strong>: PAH, LVEF &lt; 30%, severe CoA, Marfan + Ao &ge; 4.5cm, BAV + Ao &ge; 5cm, severe MS/AS, PPCM with residual LV dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Bicuspid aortic valve with aortic diameter &lt;45 mm</span></strong><span style=\"font-size:12.0pt\">: While a bicuspid aortic valve can be associated with aortic dilation, the risk is lower if the aortic diameter is less than 45 mm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Partial anomalous pulmonary venous return without pulmonary hypertension</span></strong><span style=\"font-size:12.0pt\">: This condition is generally well-tolerated and poses a lower risk in pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Systemic right ventricle</span></strong><span style=\"font-size:12.0pt\">: While this can be associated with complex congenital heart disease, it does not carry the same immediate risk of aortic complications as severe coarctation.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe aortic coarctation is a high-risk condition in pregnancy due to the increased risk of aortic dissection or rupture.</span></span></p>",
      "correct_choice_id": 214239,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53694,
      "choices": [
        {
          "id": 214249,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anakinra </span></span></span></p>"
        },
        {
          "id": 214250,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Colchicine and intravenous immune globulin (IVIG) </span></span></span></p>"
        },
        {
          "id": 214251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ibuprofen </span></span></span></p>"
        },
        {
          "id": 214252,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ibuprofen, colchicine, and prednisone</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 48-year-old man is evaluated for recurrent pericarditis. He has had two prior episodes, both successfully treated with ibuprofen and colchicine. His current symptoms include fever, pulsus paradoxus, a pericardial friction rub, and widespread ST-segment elevation on ECG. Echocardiogram shows a small pericardial effusion without tamponade. What is the most appropriate treatment?</span></span></span></p>",
      "unique_key": "Q8031880",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391935,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Ibuprofen, colchicine, and prednisone</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient has recurrent pericarditis, defined as a recurrence after a symptom-free interval of 4-6 weeks following the initial episode. Since he has already been treated with ibuprofen and colchicine, the most appropriate treatment for this recurrence is triple therapy with ibuprofen, colchicine, and a glucocorticoid like prednisone. This combination has been shown to be more effective in reducing recurrence rates compared to colchicine and NSAIDs alone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Anakinra</span></strong><span style=\"font-size:12.0pt\">: This is an interleukin-1 receptor antagonist used for refractory cases of recurrent pericarditis that have not responded to other treatments. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Colchicine and IVIG</span></strong><span style=\"font-size:12.0pt\">: This combination is also used for refractory cases, but glucocorticoids should be added first. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ibuprofen alone</span></strong><span style=\"font-size:12.0pt\">: Unlikely to be effective for recurrent pericarditis, especially since it has been used previously.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In patients with recurrent pericarditis initially treated with both colchicine and an NSAID, the addition of a glucocorticoid should be considered.</span></span></span></p>",
      "correct_choice_id": 214252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53695,
      "choices": [
        {
          "id": 214253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral Amoxicillin </span></span></span></p>"
        },
        {
          "id": 214254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral Azithromycin </span></span></span></p>"
        },
        {
          "id": 214255,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IV Clindamycin </span></span></span></p>"
        },
        {
          "id": 214256,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">No endocarditis prophylaxis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man had an atrial septal defect (ASD) closure one year ago. He is now scheduled for tooth extraction and periodontal cleaning. The dentist recommended a nil per oral (NPO) 8 hours prior to the procedure. What is the choice for IE prophylaxis?</span></span></p>",
      "unique_key": "Q4399622",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391936,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) No endocarditis prophylaxis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IE prophylaxis is not recommended for patients with repaired ASDs who do not have residual shunts or other high-risk features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IE prophylaxis is indicated only for patients at high risk for infective endocarditis who are about to undergo gingival manipulation or other procedures that break the oral mucosa.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The highest risk for IE is in patients with a prosthetic valve, previous IE, or cyanotic congenital heart disease or repaired congenital heart disease with residual flow disturbances. Other indications include cardiac transplantation valvulopathy, prosthetic material used for cardiac valve repair, and a cardiac defect that has been repaired with prosthetic material within the previous 6 months.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">A), B), C):</span></strong><span style=\"font-size:12.0pt\"> These are antibiotics used for endocarditis prophylaxis but are not indicated in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endocarditis prophylaxis is not routinely recommended for dental procedures in patients with repaired ASDs unless there are specific high-risk features.</span></span></span></p>",
      "correct_choice_id": 214256,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53697,
      "choices": [
        {
          "id": 214261,
          "text": "<p><span style=\"font-size:12.0pt;\">Large pericardial effusion</span></p>"
        },
        {
          "id": 214262,
          "text": "<p><span style=\"font-size:12.0pt;\">No pericardial effusion</span></p>"
        },
        {
          "id": 214263,
          "text": "<p><span style=\"font-size:12.0pt;\">LV dilatation</span></p>"
        },
        {
          "id": 214264,
          "text": "<p><span style=\"font-size:12.0pt;\">Indeterminate study</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient evaluated for cough is found to have an enlarged cardiac silhouette on chest radiography. He is suspected of having pericardial effusion. Ultrasonography is performed with the probe placed in the subxiphoid area. The results are shown. Which of the following is the most likely interpretation of this study?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202024-12-14%20at%2009.53.39.jpeg\" width=\"1280\" height=\"720\"></span></p>",
      "unique_key": "Q6932795",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391937,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans.</strong><span style=\"font-size:14.6667px;\">&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) Large pericardial effusion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient's ultrasound shows a large, circumferential pericardial effusion (arrows) with evidence of cardiac tamponade. An anechoic space is seen between the liver in the near field and the myocardium of the heart and also surrounds the entire heart, indicating a large effusion. Cardiac tamponade is typically seen as collapse of the right atrium or the right ventricle during the diastolic phase of the cardiac cycle. In this study, although the right ventricular free wall appears to wiggle, this is caused by inward diastolic movement typical in tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. No pericardial effusion:</strong> This option is incorrect because the ultrasound clearly demonstrates the presence of a significant anechoic space around the heart, indicating a pericardial effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. LV dilatation:</strong> Left ventricular (LV) dilatation is not indicated by the findings described in this scenario. The primary abnormality is the pericardial effusion, not an intrinsic abnormality of the left ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Indeterminate study</strong>: This option is incorrect because the ultrasound findings are definitive for a large pericardial effusion. There is no indication that the study is inconclusive or indeterminate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A large pericardial effusion is characterized by the accumulation of fluid around the heart, visible as an anechoic space on ultrasound. It can lead to cardiac tamponade, a life-threatening condition that requires prompt recognition and management.</span></p>",
      "correct_choice_id": 214261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53698,
      "choices": [
        {
          "id": 214265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiac tamponade</span></span></span></p>"
        },
        {
          "id": 214266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Constrictive pericarditis </span></span></span></p>"
        },
        {
          "id": 214267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary embolism </span></span></span></p>"
        },
        {
          "id": 214268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary hypertension</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old woman with SLE presents with progressive dyspnea, fatigue, chest fullness, and bilateral peripheral edema. She is febrile and her JVP is elevated. ECG is shown. What is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-124716.jpg\" style=\"height:283px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q3026721",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391938,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Cardiac tamponade</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s clinical presentation, including fever, jugular venous distention and electrical alternans on ECG are suggestive of cardiac tamponade. Cardiac tamponade is a life-threatening condition where fluid accumulation in the pericardial sac compresses the heart, impairing its ability to pump blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Constrictive pericarditis</span></strong><span style=\"font-size:12.0pt\">: Although it can present with similar symptoms, it usually has a more insidious onset and does not typically cause electrical alternans on ECG. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pulmonary embolism</span></strong><span style=\"font-size:12.0pt\">: Can cause dyspnea and elevated JVP, but it would not typically present with electrical alternans. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pulmonary hypertension</span></strong><span style=\"font-size:12.0pt\">: Less likely in the absence of lung disease or right heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Electrical alternans is a hallmark of cardiac tamponade.</span></span></span></p>",
      "correct_choice_id": 214265,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53700,
      "choices": [
        {
          "id": 214273,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intracranial hemorrhage </span></span></span></p>"
        },
        {
          "id": 214274,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stroke </span></span></span></p>"
        },
        {
          "id": 214275,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heart failure </span></span></span></p>"
        },
        {
          "id": 214276,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aortic dissection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man is evaluated for a 2-day history of fever, malaise, and heart murmur. Today, crops of nonpainful cutaneous lesions have appeared on his feet as shown. Given the diagnosis, the patient is at risk of all of the following except?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184301.jpg\" style=\"height:257px; width:400px\" /></span></span></p>",
      "unique_key": "Q4607365",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391939,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Aortic dissection</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image demonstrates Janeway lesions. These are nonpainful, macular (occasionally nodular), blanching lesions located on the palms of the hands and soles of the feet; they&nbsp; are associated with infective endocarditis and considered to be a part of vascular phenomenon. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coming back to the case - fever, malaise and a new heart murmur also strongly suggests infective endocarditis. While IE can rarely cause mycotic aneurysms (common the brain), aortic dissection is not a direct complication of infective endocarditis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Intracranial hemorrhage:</span></strong><span style=\"font-size:12.0pt\"> Septic emboli from IE can lodge in the brain, causing intracranial hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Stroke:</span></strong><span style=\"font-size:12.0pt\"> Septic emboli can also cause ischemic stroke.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Heart failure:</span></strong><span style=\"font-size:12.0pt\"> Valve damage from IE can lead to heart failure.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic complications are uncommon in endocarditis. </span></span></p>",
      "correct_choice_id": 214276,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53701,
      "choices": [
        {
          "id": 214277,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic thromboembolic pulmonary hypertension</span></span></span></p>"
        },
        {
          "id": 214278,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Constrictive pericarditis</span></span></span></p>"
        },
        {
          "id": 214279,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary hyperparathyroidism</span></span></span></p>"
        },
        {
          "id": 214280,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Restrictive cardiomyopathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 60-year-old man is evaluated for chronic right-sided heart failure. Chest radiographs are shown. Which of the following is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184320.jpg\" style=\"height:204px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q3389348",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391940,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Constrictive pericarditis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most likely diagnosis is constrictive pericarditis. This chest radiograph shows pericardial calcification on both the posterior-anterior (black arrow) and lateral views (white arrows). Constrictive pericarditis is characterized by pericardial thickening, fibrosis, and sometimes calcification that impair diastolic filling and limit total cardiac volume. Chest radiography or CT may demonstrate partial or circumferential pericardial calcification, and CT or cardiac magnetic resonance imaging may demonstrate pericardial thickening (&gt;3 mm). Importantly, constriction may exist in the absence of these findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Chronic thromboembolic pulmonary hypertension: </span></strong><span style=\"font-size:12.0pt\">This condition involves pulmonary artery obstruction due to organized clots, leading to increased pulmonary artery pressure and right-sided heart failure. However, it would not typically present with pericardial calcification on chest radiographs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Primary hyperparathyroidism: </span></strong><span style=\"font-size:12.0pt\">While primary hyperparathyroidism can cause hypercalcemia and possibly lead to calcifications in various tissues, it is not typically associated with pericardial calcification or the symptoms of chronic right-sided heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Restrictive cardiomyopathy</span></strong><span style=\"font-size:12.0pt\">: Restrictive cardiomyopathy causes diastolic dysfunction due to myocardial stiffness but does not involve pericardial calcification. The imaging findings and clinical presentation are more consistent with constrictive pericarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Constrictive pericarditis is characterized by pericardial thickening and calcification that leads to impaired cardiac filling and chronic right-sided heart failure. Radiographic evidence of pericardial calcification is a key diagnostic clue.</span></span></span></p>",
      "correct_choice_id": 214278,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53706,
      "choices": [
        {
          "id": 214297,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiac tamponade </span></span></span></p>"
        },
        {
          "id": 214298,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Constrictive pericarditis </span></span></span></p>"
        },
        {
          "id": 214299,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tricuspid regurgitation </span></span></span></p>"
        },
        {
          "id": 214300,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tricuspid stenosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 43-year-old patient presents with edema and elevated jugular venous pressure (JVP). The JVP pressure tracing is shown below. What is the diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184409.jpg\" style=\"height:231px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q1113602",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391941,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Constrictive pericarditis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of edema, elevated JVP, and prominent x and y descents on the JVP tracing is highly suggestive of constrictive pericarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Prominent x descent:</span></strong><span style=\"font-size:12.0pt\"> This reflects the rapid atrial emptying during early ventricular systole due to the rigid pericardium limiting ventricular filling.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Prominent y descent:</span></strong><span style=\"font-size:12.0pt\"> This represents the rapid ventricular filling during early diastole as the tricuspid valve opens, also due to the constraint imposed by the pericardium.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cardiac tamponade:</span></strong><span style=\"font-size:12.0pt\"> In cardiac tamponade, the x descent is typically absent or minimal, and the y descent is blunted or slow.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tricuspid regurgitation:</span></strong><span style=\"font-size:12.0pt\"> This would cause a prominent v wave in the JVP tracing, not a prominent x descent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tricuspid stenosis:</span></strong><span style=\"font-size:12.0pt\"> Tricuspid stenosis would cause a slow y descent, but the x descent would be normal or blunted.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prominent x and y descent is characteristic of constrictive pericarditis. The prominent &lsquo;y&rsquo; descent of constrictive pericarditis is also called as &lsquo;friedrich sign&rsquo;. </span></span></span></p>",
      "correct_choice_id": 214298,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53708,
      "choices": [
        {
          "id": 214305,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute pericarditis </span></span></span></p>"
        },
        {
          "id": 214306,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dressler&#39;s syndrome </span></span></span></p>"
        },
        {
          "id": 214307,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary embolism </span></span></span></p>"
        },
        {
          "id": 214308,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recurrent MI</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man presents with pleuritic chest pain, fever, and malaise two weeks after a myocardial infarction (MI). On auscultation, you hear a multiphasic rub. His CRP levels are elevated, and troponin levels are slightly elevated but unchanged compared to previous values. ECG shows new ST elevations. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q8929223",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391942,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Dressler&#39;s syndrome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation is classic for Dressler&#39;s syndrome:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Timing:</span></strong><span style=\"font-size:12.0pt\"> Occurs 1-8 weeks after MI.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Symptoms:</span></strong><span style=\"font-size:12.0pt\"> Pleuritic chest pain, fever, malaise.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Exam:</span></strong><span style=\"font-size:12.0pt\"> Pericardial friction rub.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Labs:</span></strong><span style=\"font-size:12.0pt\"> Elevated CRP, slightly elevated but unchanged troponin.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">ECG:</span></strong><span style=\"font-size:12.0pt\"> New ST elevations (due to pericardial inflammation).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Acute pericarditis:</span></strong><span style=\"font-size:12.0pt\"> Less likely given the recent MI.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pulmonary embolism:</span></strong><span style=\"font-size:12.0pt\"> Unlikely with unchanged troponin and ECG findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Recurrent MI:</span></strong><span style=\"font-size:12.0pt\"> Unlikely with unchanged troponin and ECG findings suggestive of pericarditis.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dressler&#39;s syndrome is a post-MI pericarditis that occurs after 1-2 weeks. </span></span></span></p>",
      "correct_choice_id": 214306,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53709,
      "choices": [
        {
          "id": 214309,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bartonella serology </span></span></span></p>"
        },
        {
          "id": 214310,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Epstein-Barr virus heterophile antibody </span></span></span></p>"
        },
        {
          "id": 214311,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HIV polymerase chain reaction </span></span></span></p>"
        },
        {
          "id": 214312,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Q fever serology</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 38-year-old homeless man presents with TIA, fever, chills, tender splenomegaly, new painful nodules on fingers, and nits on clothes. Blood cultures are negative, but echo reveals aortic valve vegetation. What test should be sent to confirm the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q1862658",
      "question_audio": null,
      "question_video": null,
      "map_id": 16391943,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Bartonella serology</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient has culture-negative endocarditis. Culture-negative endocarditis accounts for &lt;10% of cases in all populations. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A common reason for negative blood cultures is prior antibiotics. In the absence of this,&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">the two most common pathogens are Q fever, or Coxiella burnetii (typically associated with close contact with livestock), and Bartonella. In this case, the patient&rsquo;s homelessness and body louse infestation are clues for B. quintana infection. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diagnosis is made by blood culture about 25% of the time. Otherwise, direct PCR of valvular tissue, if available, or acute and convalescent serologies are diagnostic options. Empirical therapy for culture-negative endocarditis usually includes ceftriaxone + gentamicin, with or without doxycycline. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><em><u><span style=\"font-size:12.0pt\">For confirmed Bartonella endocarditis, optimal therapy is gentamicin + doxycycline</span></u></em></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Epstein-Barr virus heterophile antibody:</span></strong><span style=\"font-size:12.0pt\"> EBV does not typically cause endocarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. HIV polymerase chain reaction:</span></strong><span style=\"font-size:12.0pt\"> HIV does not cause endocarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Q fever serology:</span></strong><span style=\"font-size:12.0pt\"> While Q fever can cause culture-negative endocarditis, the patient&#39;s history and presentation are more consistent with Bartonella infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Two most common pathogens responsible for culture negative endocarditis re</span></span></span></p>",
      "correct_choice_id": 214309,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53999,
      "choices": [
        {
          "id": 215465,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Focal segmental glomerulosclerosis (FSGS)</span></span></span></p>"
        },
        {
          "id": 215466,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Hypertensive nephrosclerosis </span></span></span></p>"
        },
        {
          "id": 215467,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Minimal change disease </span></span></span></p>"
        },
        {
          "id": 215468,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Crescentic glomerulonephritis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old obese woman with controlled hypertension has nephrotic-range proteinuria and mild edema. Renal biopsy reveals segmental scarring in 60% of glomeruli, mainly at the corticomedullary junction. Which diagnosis is most likely?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-163558.jpg\" style=\"height:240px; width:350px\" /></span></span></p>",
      "unique_key": "Q5623780",
      "question_audio": null,
      "question_video": null,
      "map_id": 16392104,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Ans. A) Focal segmental glomerulosclerosis (FSGS)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">FSGS:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;The biopsy finding of segmental scarring in a subset of glomeruli, especially in the corticomedullary junction, is characteristic of FSGS. Additionally, the patient&#39;s obesity is a known risk factor for FSGS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B. Hypertensive nephrosclerosis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;While the patient has hypertension, the biopsy findings do not fit the typical pattern of nephrosclerosis (arteriolosclerosis and global glomerulosclerosis).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. Minimal change disease:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;This would usually present with less severe proteinuria and no glomerular scarring on biopsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D. Crescentic glomerulonephritis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;This is a rapidly progressive form of glomerulonephritis with crescents (proliferations of cells) on biopsy, not present in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Focal segmental glomerulosclerosis (FSGS) is characterized by segmental scarring in a subset of glomeruli, often associated with obesity.</span></span></span></p>",
      "correct_choice_id": 215465,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54001,
      "choices": [
        {
          "id": 215473,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">1-3 weeks</span></span></span></p>"
        },
        {
          "id": 215474,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2-6 weeks</span></span></p>"
        },
        {
          "id": 215475,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3-8 weeks</span></span></p>"
        },
        {
          "id": 215476,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">2-6 days</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">A 5-year-old boy presents with hematuria and edema, three weeks after a confirmed case of impetigo. Which of the following is the most appropriate time frame for the development of post-streptococcal glomerulonephritis (PSGN) following impetigo?</span></span></span></p>",
      "unique_key": "Q8294364",
      "question_audio": null,
      "question_video": null,
      "map_id": 16392105,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Ans. B) 2-6 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">The typical time frame for the development of PSGN after impetigo is 2-6 weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A. 1-3 weeks:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> This time frame is too short for PSGN to develop after a streptococcal infection like impetigo.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. 3-8 weeks:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> While PSGN can occasionally present slightly later, the most typical window is within the first 2-6 weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D. 2-6 days:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> This time frame is far too short. PSGN takes weeks, not days, to manifest.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-streptococcal glomerulonephritis (PSGN) is an immune-mediated complication that can occur after a streptococcal infection. The classic presentation includes hematuria (blood in the urine), edema (swelling) and hypertension. The most common time frame for the development of PSGN following a streptococcal infection is <strong>2-6 weeks</strong>. Recognizing this typical time frame is crucial for timely diagnosis and management of PSGN.</span></span></p>",
      "correct_choice_id": 215474,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54003,
      "choices": [
        {
          "id": 215481,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangial cell proliferation </span></span></p>"
        },
        {
          "id": 215482,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linear IgG deposits along the glomerular basement membrane </span></span></p>"
        },
        {
          "id": 215483,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Subepithelial immune complex deposits </span></span></span></p>"
        },
        {
          "id": 215484,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mesangial IgA deposits</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old man presents with hemoptysis (coughing up blood), shortness of breath and hematuria. His serum creatinine is elevated. A renal biopsy is taken and immunofluorescence is shown below. Given the likely diagnosis, what would be the immunofluorescence findings?&nbsp; </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-164723_IdSR2Ar.jpg\" style=\"height:225px; width:309px\" /></p>\r\n\r\n<p>&nbsp;</p>",
      "unique_key": "Q8036055",
      "question_audio": null,
      "question_video": null,
      "map_id": 16392106,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Ans. B) Linear IgG deposits along the glomerular basement membrane</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Linear IgG deposits on immunofluorescence are a hallmark of anti-GBM disease, the underlying cause of Goodpasture syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A. Mesangial cell proliferation:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> Is seen in IgA nephropathy and other conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. Subepithelial immune complex deposits:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> Are characteristic of membranous nephropathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D. Mesangial IgA deposits:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> Are seen in IgA nephropathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Linear IgG deposits along the glomerular basement membrane on immunofluorescence are characteristic of Goodpasture syndrome (anti-GBM disease).</span></span></span></p>",
      "correct_choice_id": 215482,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54007,
      "choices": [
        {
          "id": 215497,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">IgA nephropathy </span></span></span></p>"
        },
        {
          "id": 215498,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Thin basement membrane nephropathy (TBMN) </span></span></span></p>"
        },
        {
          "id": 215499,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Alport syndrome </span></span></span></p>"
        },
        {
          "id": 215500,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Minimal change disease (MCD)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">A 10-year-old boy presents with recurrent hematuria and a family history of kidney disease, on further questioning he has difficulty in hearing since childhood. A renal biopsy reveals thin glomerular basement membranes (GBMs) on electron microscopy. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q2885120",
      "question_audio": null,
      "question_video": null,
      "map_id": 16392107,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Ans. C) Alport syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Thin GBM is an early and characteristic finding in young Alport syndrome patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">. </span><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">IgA nephropathy:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;Presents with mesangial IgA deposits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B. Thin basement membrane nephropathy</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> (</span><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">TBMN)</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">:&nbsp;This is a benign condition with persistent thin GBM,&nbsp;but no progression to multilamellation or other Alport features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D. Minimal change disease (</span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MCD):</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;Does not cause thinning of the GBM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Alport syndrome is primarily inherited in an X-linked dominant pattern (approximately 85%), but 15% of cases follow an autosomal recessive pattern.</span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Thin glomerular basement membranes (GBMs) on electron microscopy, combined with recurrent hematuria and a family history of kidney disease and hearing loss, are suggestive of Alport syndrome.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 215499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54010,
      "choices": [
        {
          "id": 215509,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Proteinuria &gt; 3.5 g/day </span></span></span></p>"
        },
        {
          "id": 215510,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Hypoalbuminemia </span></span></span></p>"
        },
        {
          "id": 215511,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Hyperlipidemia </span></span></span></p>"
        },
        {
          "id": 215512,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Hyperkalemia</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a typical feature of nephrotic syndrome?</span></span></p>",
      "unique_key": "Q6938068",
      "question_audio": null,
      "question_video": null,
      "map_id": 16392108,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>D) Hyperkalemia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Hyperkalemia is not a characteristic finding in nephrotic syndrome. In fact, hypokalemia can occur due to diuretic use or other factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A. Proteinuria &gt; 3.5 g/day:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> This is a hallmark of nephrotic syndrome. The excessive loss of protein in the urine is a defining characteristic.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B. Hypoalbuminemia:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> This occurs due to the significant loss of albumin (a protein) in the urine, leading to low albumin levels in the blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. Hyperlipidemia:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> The liver tries to compensate for the protein loss by increasing the production of lipids (fats), leading to high levels of cholesterol and triglycerides in the blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Nephrotic syndrome is characterized by a constellation of findings, including heavy proteinuria, low albumin levels, and elevated lipids. Hyperkalemia (high potassium) is not typically associated with nephrotic syndrome; in fact, <strong>hypokalemia</strong> (low potassium) is more common due to urinary losses.</span></span></span></p>",
      "correct_choice_id": 215512,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54011,
      "choices": [
        {
          "id": 215513,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Sub-endothelial immune complex deposits </span></span></span></p>"
        },
        {
          "id": 215514,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Mesangial electron-dense deposits </span></span></span></p>"
        },
        {
          "id": 215515,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Thinning of the glomerular basement membrane </span></span></span></p>"
        },
        {
          "id": 215516,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Effacement of podocyte foot processes</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old boy presents with generalized edema, massive proteinuria, and hypoalbuminemia. Given the likely diagnosis, what would be electron microscopic findings would be present in this patient? </span></span></p>",
      "unique_key": "Q6510499",
      "question_audio": null,
      "question_video": null,
      "map_id": 16392109,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>D) Effacement of podocyte foot processes</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">The clinical presentation of generalized edema, massive proteinuria, and hypoalbuminemia is consistent with nephrotic syndrome. In children, the most common cause of nephrotic syndrome is minimal change disease. The hallmark of MCD on electron microscopy is the effacement of podocyte foot processes, which are essential for the glomerular filtration barrier.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A. Sub-endothelial immune complex deposits:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;This is typically seen in lupus nephritis and other immune-complex mediated glomerulonephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B. Mesangial electron-dense deposits:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;This is characteristic of IgA nephropathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. Thinning of the glomerular basement membrane:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">&nbsp;This is seen in thin basement membrane nephropathy,&nbsp;a benign condition with minimal proteinuria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation strongly suggests <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">minimal change disease (MCD)</span></strong>, which is the most common cause of nephrotic syndrome in children. The hallmark electron microscopic finding in MCD is the <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">effacement (flattening or fusion) of podocyte foot processes</span></strong>. These foot processes are crucial for the filtration barrier in the glomerulus and their damage leads to the massive proteinuria seen in nephrotic syndrome.</span></span></span></span></p>",
      "correct_choice_id": 215516,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54015,
      "choices": [
        {
          "id": 215529,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MPGN type I </span></span></span></p>"
        },
        {
          "id": 215530,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MPGN type II </span></span></span></p>"
        },
        {
          "id": 215531,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MPGN type III </span></span></span></p>"
        },
        {
          "id": 215532,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Alport syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is associated with &ldquo;tram-track&rdquo; appearance of renal biopsy? </span></span></p>",
      "unique_key": "Q2505062",
      "question_audio": null,
      "question_video": null,
      "map_id": 16392110,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>A) MPGN type I</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">The &quot;tram-track&quot; appearance is due to mesangial interposition between the GBM and endothelial cells, a characteristic finding in MPGN type I.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option B. MPGN type II:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> &nbsp;Shows dense deposits within the GBM,&nbsp;not the tram-track appearance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C. MPGN type III:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> &nbsp;Is similar to type I but with less prominent mesangial interposition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option D. Alport syndrome:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"> Shows splitting and lamellation of the GBM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">The &quot;tram-track&quot; appearance on renal biopsy is a hallmark of MPGN type I due to the characteristic mesangial interposition. This distinctive finding helps differentiate MPGN type I from other glomerular diseases.</span></span></span></p>",
      "correct_choice_id": 215529,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54016,
      "choices": [
        {
          "id": 215533,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">The majority of patients will experience spontaneous remission within 5 years. </span></span></span></p>"
        },
        {
          "id": 215534,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Renal function typically remains stable for at least 20 years after diagnosis. </span></span></span></p>"
        },
        {
          "id": 215535,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Approximately 50% of patients will develop end-stage renal disease (ESRD) within 10 years. </span></span></span></p>"
        },
        {
          "id": 215536,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Early treatment with corticosteroids can prevent progression to ESRD in most cases.</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old patient is newly diagnosed with idiopathic membranoproliferative glomerulonephritis (MPGN) type I. Which of the following statements regarding their prognosis is MOST accurate?</span></span></p>",
      "unique_key": "Q7400597",
      "question_audio": null,
      "question_video": null,
      "map_id": 16392111,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>C) Approximately 50% of patients will develop end-stage renal disease (ESRD) within 10 years</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MPGN type I is a progressive disease, and studies have shown that about 50% of patients will develop ESRD within 10 years of diagnosis. This underscores the importance of early diagnosis and appropriate management to slow disease progression.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>The majority of patients will experience spontaneous remission within 5 years</strong>:&nbsp; Spontaneous remission is rare in MPGN type I.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>Renal function typically remains stable for at least 20 years after diagnosis:&nbsp; </strong>Renal function typically declines over time,&nbsp;with 90% of patients developing renal insufficiency within 20 years.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\"><strong>Early treatment with corticosteroids can prevent progression to ESRD in most cases: </strong>&nbsp;While corticosteroids may be beneficial in some cases,&nbsp;they do not guarantee prevention of ESRD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:14.0pt\">MPGN type I is a progressive disease with a poor prognosis. Approximately half of the patients progress to ESRD within 10 years, emphasizing the need for early diagnosis and management to potentially slow disease progression. While treatments like corticosteroids may be used, they do not guarantee prevention of ESRD.</span></span></span></p>",
      "correct_choice_id": 215535,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6825,
      "choices": [
        {
          "id": 27269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Dual chamber Pacemaker</span></span></p>"
        },
        {
          "id": 27270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Single chamber pacemaker</span></span></p>"
        },
        {
          "id": 27271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">CRT device</span></span></p>"
        },
        {
          "id": 27272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Swan Ganz catheter</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following diagnoses is most consistent with the radiographic findings shown?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-112453.png\" style=\"height:195px; width:400px\" /></span></span></p>",
      "unique_key": "Q5689864",
      "question_audio": null,
      "question_video": null,
      "map_id": 16392592,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Dual chamber Pacemaker</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The radiographic image shows leads in the right atrium (RA) and right ventricle (RV), consistent with a dual chamber pacemaker. This type of pacemaker is used to provide electrical stimulation to both the atrium and the ventricle, helping to coordinate the heart&#39;s rhythm. This patient in addition has features of pulmonary edema as well. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Single chamber pacemaker:</span></strong><span style=\"font-size:12.0pt\"> A single chamber pacemaker has only one lead, typically in the RV. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. CRT device:</span></strong><span style=\"font-size:12.0pt\"> A CRT device would include an additional lead positioned to pace the left ventricle via the coronary sinus, which is not seen in this image. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Swan Ganz catheter:</span></strong><span style=\"font-size:12.0pt\"> A Swan-Ganz catheter, used for measuring hemodynamic parameters, is not an implantable device and would appear as a different configuration on imaging.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A dual chamber pacemaker has leads placed in both the right atrium and right ventricle. This device is used to maintain coordinated atrial and ventricular pacing in patients with specific types of heart block or other cardiac rhythm disturbances.</span></span></span></p>",
      "correct_choice_id": 27269,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}